Kyle Jenne

Business address
C/O Akcea Therapeutics, Inc., 22 Boston Wharf Road, 9 Th Floor, Boston, MA, 02210
Top holdings (ownership)
IONS
Get insider transactions for this reporting owner
Kyle Jenne has filed 12 SEC EDGAR filings since 23 Oct 2019

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing PRIMARY DOCUMENT 17 Apr 2025 15 Apr 2025 000-19125
144 Open Document Open Filing 16 Apr 2025
4 Open Document Open Filing PRIMARY DOCUMENT 17 Jan 2025 15 Jan 2025 000-19125
4 Open Document Open Filing PRIMARY DOCUMENT 06 Jan 2025 02 Jan 2025 000-19125
4 Open Document Open Filing PRIMARY DOCUMENT 13 Mar 2024 26 Feb 2024 000-19125
3 Open Document Open Filing PRIMARY DOCUMENT 13 Mar 2024 26 Feb 2024 000-19125
4 Open Document Open Filing FORM 4 SUBMISSION 13 Oct 2020 12 Oct 2020 001-38137
4 Open Document Open Filing FORM 4 SUBMISSION 24 Sep 2020 22 Sep 2020 001-38137
4 Open Document Open Filing FORM 4 SUBMISSION 25 Mar 2020 23 Mar 2020 001-38137
4 Open Document Open Filing FORM 4 SUBMISSION 23 Mar 2020 19 Mar 2020 001-38137
4 Open Document Open Filing FORM 4 SUBMISSION 23 Oct 2019 21 Oct 2019 001-38137
3 Open Document Open Filing FORM 3 SUBMISSION 23 Oct 2019 21 Oct 2019 001-38137